| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
|
Ther Drug Monit
|
2009
|
1.68
|
|
2
|
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.
|
Clin Chem
|
2011
|
1.64
|
|
3
|
Acute barium intoxication and hemodiafiltration.
|
J Toxicol Clin Toxicol
|
2003
|
1.55
|
|
4
|
Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation.
|
J Surg Res
|
2012
|
1.45
|
|
5
|
Adverse health effects of child labor: high exposure to chromium and oxidative DNA damage in children manufacturing surgical instruments.
|
Environ Health Perspect
|
2012
|
1.44
|
|
6
|
Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA.
|
Carcinogenesis
|
2004
|
1.28
|
|
7
|
Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors' dose requirements and trough blood levels in stable renal transplant patients.
|
Pharmacogenomics
|
2011
|
1.27
|
|
8
|
Associations of urinary cadmium with age and urinary proteins: further evidence of physiological variations unrelated to metal accumulation and toxicity.
|
Environ Health Perspect
|
2013
|
1.22
|
|
9
|
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.
|
Pharmacogenomics
|
2013
|
1.21
|
|
10
|
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids.
|
Transplantation
|
2005
|
1.21
|
|
11
|
Confounders in the assessment of the renal effects associated with low-level urinary cadmium: an analysis in industrial workers.
|
Environ Health
|
2011
|
1.21
|
|
12
|
High human exposure to cobalt and other metals in Katanga, a mining area of the Democratic Republic of Congo.
|
Environ Res
|
2009
|
1.12
|
|
13
|
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patients.
|
Pharmacogenet Genomics
|
2012
|
1.09
|
|
14
|
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study.
|
Pharmacogenet Genomics
|
2011
|
1.09
|
|
15
|
The threshold level of urinary cadmium associated with increased urinary excretion of retinol-binding protein and beta 2-microglobulin: a re-assessment in a large cohort of nickel-cadmium battery workers.
|
Occup Environ Med
|
2010
|
1.05
|
|
16
|
Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides.
|
Ann Pharmacother
|
2005
|
1.04
|
|
17
|
Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant.
|
Environ Mol Mutagen
|
2004
|
0.95
|
|
18
|
Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.
|
Pharmacogenomics
|
2010
|
0.95
|
|
19
|
A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
|
J Clin Pharmacol
|
2011
|
0.93
|
|
20
|
Reference values and upper reference limits for 26 trace elements in the urine of adults living in Belgium.
|
Clin Chem Lab Med
|
2013
|
0.93
|
|
21
|
Elevated blood lead levels and sources of exposure in the population of Kinshasa, the capital of the Democratic Republic of Congo.
|
J Expo Sci Environ Epidemiol
|
2012
|
0.92
|
|
22
|
1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation.
|
Pharmacogenet Genomics
|
2007
|
0.92
|
|
23
|
Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
|
Ther Drug Monit
|
2009
|
0.91
|
|
24
|
Plasma and tissue determination of 4-methylpyrazole for pharmacokinetic analysis in acute adult and pediatric methanol/ethylene glycol poisoning.
|
Ther Drug Monit
|
2004
|
0.91
|
|
25
|
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.
|
Pharmacogenomics
|
2010
|
0.90
|
|
26
|
Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients.
|
Ther Drug Monit
|
2014
|
0.88
|
|
27
|
CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin.
|
Pharmacogenomics
|
2013
|
0.88
|
|
28
|
Acute renal injury following methanol poisoning: analysis of a case series.
|
Int J Toxicol
|
2004
|
0.87
|
|
29
|
Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.
|
Ther Drug Monit
|
2013
|
0.87
|
|
30
|
Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study.
|
Transpl Int
|
2011
|
0.87
|
|
31
|
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation.
|
Ther Drug Monit
|
2016
|
0.86
|
|
32
|
Influence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers.
|
Environ Mol Mutagen
|
2004
|
0.86
|
|
33
|
Evaluation of urinary biomarkers of exposure to benzene: correlation with blood benzene and influence of confounding factors.
|
Int Arch Occup Environ Health
|
2008
|
0.85
|
|
34
|
Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition.
|
Pharmacogenet Genomics
|
2011
|
0.85
|
|
35
|
The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.84
|
|
36
|
Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy.
|
Ther Drug Monit
|
2012
|
0.84
|
|
37
|
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function.
|
Clin Chem Lab Med
|
2006
|
0.84
|
|
38
|
Genetic polymorphisms and possible gene-gene interactions in metabolic and DNA repair genes: effects on DNA damage.
|
Mutat Res
|
2005
|
0.84
|
|
39
|
Serum pneumoproteins and biomarkers of exposure to urban air pollution: a cross-sectional comparison of policemen and foresters.
|
Biomarkers
|
2005
|
0.83
|
|
40
|
Occupational exposure to indium: what does biomonitoring tell us?
|
Toxicol Lett
|
2011
|
0.83
|
|
41
|
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
|
Transplantation
|
2008
|
0.83
|
|
42
|
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
|
Pharmacogenomics
|
2014
|
0.83
|
|
43
|
Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats.
|
Bone
|
2005
|
0.82
|
|
44
|
Bone resorption and environmental exposure to cadmium in children: a cross--sectional study.
|
Environ Health
|
2011
|
0.82
|
|
45
|
Thicker is better? Synthesis and evaluation of well-defined polymer brushes with controllable catalytic loadings.
|
Chemistry
|
2012
|
0.82
|
|
46
|
Acute cardiogenic shock after lumbar sympathectomy by phenol injection.
|
Intensive Care Med
|
2001
|
0.81
|
|
47
|
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
|
Ther Drug Monit
|
2009
|
0.81
|
|
48
|
Insights into the function of YciM, a heat shock membrane protein required to maintain envelope integrity in Escherichia coli.
|
J Bacteriol
|
2013
|
0.81
|
|
49
|
Manganese in plasma: a promising biomarker of exposure to Mn in welders. A pilot study.
|
Toxicol Lett
|
2011
|
0.81
|
|
50
|
Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin.
|
Pharmacogenet Genomics
|
2013
|
0.81
|
|
51
|
Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
|
Clin Toxicol (Phila)
|
2011
|
0.80
|
|
52
|
Prior lung inflammation impacts on body distribution of gold nanoparticles.
|
Biomed Res Int
|
2013
|
0.79
|
|
53
|
Electrocardiographic changes with segmental akinesia after chloral hydrate overdose.
|
J Emerg Med
|
2006
|
0.79
|
|
54
|
Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization?
|
Intensive Care Med
|
2012
|
0.79
|
|
55
|
Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients.
|
Pharmacogenomics
|
2009
|
0.79
|
|
56
|
Lung epithelium injury biomarkers in workers exposed to sulphur dioxide in a non-ferrous smelter.
|
Biomarkers
|
2009
|
0.78
|
|
57
|
Clinical evaluation of a lead mobilization test using the chelating agent dimercaptosuccinic acid.
|
Clin Chem
|
2005
|
0.78
|
|
58
|
Acute arsenic poisoning treated by intravenous dimercaptosuccinic acid (DMSA) and combined extrarenal epuration techniques.
|
J Toxicol Clin Toxicol
|
2003
|
0.78
|
|
59
|
Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
|
Arch Toxicol
|
2003
|
0.78
|
|
60
|
Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs.
|
Ther Drug Monit
|
2016
|
0.77
|
|
61
|
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen.
|
Pharmacogenomics
|
2015
|
0.77
|
|
62
|
Fomepizole therapy for reversal of visual impairment after methanol poisoning: a case documented by visual evoked potentials investigation.
|
Am J Ophthalmol
|
2002
|
0.77
|
|
63
|
Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
|
Clin Chem
|
2008
|
0.77
|
|
64
|
Comparison of atomic absorption and fluorescence spectroscopic methods for the routine determination of urinary arsenic.
|
Int Arch Occup Environ Health
|
2005
|
0.76
|
|
65
|
Chromate or titanium allergy -- the role of impurities?
|
Contact Dermatitis
|
2013
|
0.76
|
|
66
|
In vivo visualization and ex vivo quantification of murine breast cancer cells in the mouse brain using MRI cell tracking and electron paramagnetic resonance.
|
NMR Biomed
|
2015
|
0.76
|
|
67
|
Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs.
|
Arch Toxicol
|
2002
|
0.76
|
|
68
|
Dimethylformamide metabolism following self-harm using a veterinary euthanasia product.
|
Clin Toxicol (Phila)
|
2010
|
0.76
|
|
69
|
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation.
|
Ther Drug Monit
|
2015
|
0.75
|
|
70
|
(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.
|
Nanomedicine (Lond)
|
2014
|
0.75
|
|
71
|
Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation.
|
Br J Clin Pharmacol
|
2013
|
0.75
|
|
72
|
Acute intoxication with nevirapine in an HIV-1-infected patient: clinical and pharmacokinetic follow up.
|
AIDS
|
2009
|
0.75
|
|
73
|
Biological monitoring and health effects of low-level exposure to N-methyl-2-pyrrolidone: a cross-sectional study.
|
Int Arch Occup Environ Health
|
2014
|
0.75
|
|
74
|
Invasive aspergillosis in association with criminal arsenic poisoning.
|
J Clin Forensic Med
|
2005
|
0.75
|
|
75
|
Grafting control of mainstay terpyridine self-assembled monolayers for the preparation of planar silicon surfaces with variable catalytic loadings.
|
Langmuir
|
2012
|
0.75
|